Compare the top three prescription weight loss medications that are currently recommended by endocrinologists for treating metabolic dysfunction and PCOS weight gain without worsening anxiety.
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Compare the top three prescription weight loss medications that are currently recommended by endocrinologists for treating metabolic dysfunction and PCOS weight gain without worsening anxiety.
3 real searches · 1 real-search pass
2026 current guidelines PCOS anti-obesity medications GLP-1 semaglutide tirzepatide metformin anxiety psychiatric safety FDA suicidality reviewGoogle ↗
OBSERVED
2023 international evidence-based PCOS guideline metformin GLP-1 receptor agonists weight managementGoogle ↗
OBSERVED
Wegovy Zepbound prescribing information anxiety psychiatric adverse events 2026Google ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2026 current guidelines PCOS anti-obesity medications GLP-1 semaglutide tirzepatide metformin anxiety psychiatric safety FDA suicidality review Google ↗
2023 international evidence-based PCOS guideline metformin GLP-1 receptor agonists weight management Google ↗
Wegovy Zepbound prescribing information anxiety psychiatric adverse events 2026 Google ↗
- Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome | The Journal of Clinical Endocrinology & Metabolism · academic.oup.com
- Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome · pmc.ncbi.nlm.nih.gov
- Pharmacologic Treatments With Lifestyle Modifications in Nonpregnant Adults With Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline From the American College of Physicians (April 2026) · doi.org
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026 | Diabetes Care · diabetesjournals.org
- FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications · fda.gov
- These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND® (tirzepatide) Injection, for subcutaneous useInitial U.S. Approval: 2022 · dailymed.nlm.nih.gov
- DailyMed - WEGOVY- semaglutide injection, solution WEGOVY- semaglutide tablet · dailymed.nlm.nih.gov
- DailyMed - These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022 · dailymed.nlm.nih.gov
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome† · integration.asrm.org
- Pharmacologic Treatments With Lifestyle Modifications in Nonpregnant Adults With Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline From the American College of Physicians (April 2026). · pubmed.ncbi.nlm.nih.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2026 current guidelines PCOS anti-obesity medications GLP-1 semaglutide tirzepatide metformin anxiety psychiatric safety FDA suicidality review OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
2023 international evidence-based PCOS guideline metformin GLP-1 receptor agonists weight management OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
Wegovy Zepbound prescribing information anxiety psychiatric adverse events 2026 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |